In vitro selection of high-affinity nucleic acid ligands to parasite target molecules

International Journal for Parasitology

Volumn 33, Issue 12, 2003, Pages 1309-1317

  Göringer, H Ulrich ^a   Homann, Matthias ^a   Lorger, Mihaela ^a,b  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

African trypanosome; Aptamer; Combinatorial chemistry; In vitro evolution; SELEX; Systematic evolution of ligands by exponential enrichment; Trypanosoma cruzi

Indexed keywords

APTAMER; LIGAND; NUCLEIC ACID;

LIGAND; NUCLEIC ACID; PARASITE;

BINDING AFFINITY; CELL ACTIVITY; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL ISOLATION; COMBINATORIAL CHEMISTRY; DNA FLANKING REGION; DNA LIBRARY; LIGAND BINDING; NONHUMAN; PROTEIN TARGETING; REVIEW; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT; TECHNIQUE; TRYPANOSOMA;

DARWINIA; SYNTHETIC CONSTRUCT; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0141756136     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(03)00197-8     Document Type: Article

References (73)

1. Andreopoulos S. Developing drugs for parasitic diseases. Science. 300:2003;430-431.
2. Barrett M.P., Gilbert I.H. Perspectives for new drugs against trypanosomiasis and leishmaniasis. Curr. Top. Med. Chem. 2:2002;471-482.
3. Bittker J.A., Phillips K.J., Liu D.R. Recent advances in the in vitro evolution of nucleic acids. Curr. Opin. Chem. Biol. 6:2002;367-374.
4. Blum M.L., Down J.A., Gurnett A.M., Carrington M., Turner M.J., Wiley D.C. A structural motif in the variant surface glycoproteins of Trypanosoma brucei. Nature. 362:1993;603-609.
5. Bock L.C., Griffin L.C., Latham J.A., Vermaas E.H., Toole J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature. 355:1992;564-566.
6. Borst P., Fairlamb A.H. Surface receptors and transporters of Trypanosoma brucei. Annu. Rev. Microbiol. 52:1998;745-778.
7. Brody E.N., Gold L. Aptamers as therapeutic and diagnostic agents. J. Biotechnol. 74:2000;5-13.
8. Brody E.N., Willis M.C., Smith J.D., Jayasena S., Zichi D., Gold L. The use of aptamers in large arrays for molecular diagnostics. Mol. Diagn. 4:1999;381-388.
9. Burgstaller P., Girod A., Blind M. Aptamers as tools for target prioritization and lead identification. Drug Discov. Today. 7:2002;1221-1228.
10. Capron A., Capron M., Riveau G. Vaccine development against schistosomiasis from concepts to clinical trials. Br. Med. Bull. 62:2002;139-148.
11. Caruthers M.H. Gene synthesis machines: DNA chemistry and its uses. Science. 230:1985;281-285.
12. Conn G.L., Draper D.E. RNA structure. Curr. Opin. Struct. Biol. 8:1998;278-285.
13. Cross G.A.M. Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei. Parasitology. 71:1975;393-417.
14. Cross G.A.M. Antigenic variation in trypanosomes: secrets surface slowly. Bioassays. 18:1996;283-291.
15. Davis J.P., Janjic N., Javornik B.E., Zichi D.A. Identifying consensus patterns and secondary structure in SELEX sequence sets. Methods Enzymol. 267:1996;302-314.
16. De Almeida M.L.C., Turner M.J. The membrane form of variant surface glycoproteins of Trypanosoma brucei. Exp. Nature. 302:1983;349-352.
17. DeAnda A. Jr, Coutre S.E., Moon M.R., Vial C.M., Griffin L.C., Law V.S., Komeda M., Leung L.L., Miller D.C. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass. Ann. Thorac. Surg. 58:1994;344-350.
18. Dias J.C., Silveira A.C., Schofield C.J. The impact of Chagas disease control in Latin America: a review. Mem. Inst. Oswaldo Cruz. 97:2002;603-612.
19. Docampo R., Moreno S.N. Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites. Curr. Drug Targets Infect. Disord. 1:2001;51-61.
20. Drolet D.W., Jenison R.D., Smith D.E., Pratt D., Hicke B.J. A high throughput platform for systematic evolution of ligands by exponential enrichment (SELEX). Comb. Chem. High Throughput Screen. 2:1999;271-278.
21. Drolet D.W., Nelson J., Tucker C.E., Zack P.M., Nixon K., Bolin R., Judkins M.B., Farmer J.A., Wolf J.L., Gill S.C., Bendele R.A. Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm. Res. 17:2000;1503-1510.
22. Eaton B.E., Pieken W.A. Ribonucleosides and RNA. Annu. Rev. Biochem. 64:1995;837-863.
23. Eccleston M.E., Kuiper M., Gilchrist F.M., Slater N.K. pH-responsive pseudo-peptides for cell membrane disruption. J. Controlled Release. 69:2000;297-307.
24. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature. 346:1990;818-822.
25. Fitzwater T., Polisky B. A SELEX primer. Methods Enzymol. 267:1996;275-301.
26. Freymann D., Down J., Carrington M., Roditi I., Turner M., Wiley D. 2.9 Å resolution structure of the N-terminal domain of a variant surface glycoprotein from Trypanosoma brucei. J. Mol. Biol. 216:1990;141-160.
27. Giordano R., Chammas R., Veiga S.S., Colli W., Alves M.J. Trypanosoma cruzi binds to laminin in a carbohydrate-independent way. Braz. J. Med. Biol. Res. 27:1994;2315-2318.
28. Giordano R., Fouts D.L., Tewari D., Colli W., Manning J.E., Alves M.J. Cloning of a surface membrane glycoprotein specific for the infective form of Trypanosoma cruzi having adhesive properties to laminin. J. Biol. Chem. 274:1999;3461-3468.
29. Gold L. Oligonucleotides as research, diagnostic, and therapeutic agents. J. Biol. Chem. 270:1995;13581-13584.
30. Gold L., Polisky B., Uhlenbeck O., Yarus M. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64:1995;763-797.
31. Goncalves M.F., Umezawa E.S., Katzin A.M., de Souza W., Alves M.J., Zingales B., Colli W. Trypanosoma cruzi: shedding of surface antigens as membrane vesicles. Exp. Parasitol. 72:1991;43-53.
32. Green L.S., Bell C., Janjic N. Aptamers as reagents for high-throughput screening. Biotechniques. 30:2001;1094-1110.
33. Griffin L.C., Tidmarsh G.F., Bock L.C., Toole J.J., Leung L.L. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood. 81:1993;3271-3276.
34. Hermann T., Patel D.J. Adaptive recognition by nucleic acid aptamers. Science. 287:2000;820-825.
35. Herrera E.M., Ming M., Ortega-Barria E., Pereira M.E. Mediation of Trypanosoma cruzi invasion by heparan sulfate receptors on host cells and penetrin counter-receptors on the trypanosomes. Mol. Biochem. Parasitol. 65:1994;73-83.
36. Hesselberth J., Robertson M.P., Jhaveri S., Ellington A.D. In vitro selection of nucleic acids for diagnostic applications. J. Biotechnol. 74:2000;15-25.
37. Homann M., Göringer H.U. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res. 27:1999;2006-2014.
38. Homann M., Göringer H.U. Uptake and intracellular transport of RNA aptamers in African trypanosomes suggest therapeutic 'piggy-back' approach. Bioorg. Med. Chem. 9:2001;2571-2580.
39. Jacobson A.B., Zuker M. Structural analysis by energy dot plot of a large mRNA. J. Mol. Biol. 233:1993;261-269.
40. Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 45:1999;1628-1650.
41. Johnson J.G., Cross G.A. Selective cleavage of variant surface glycoproteins from Trypanosoma brucei. Biochem. J. 178:1979;689-697.
42. Kaiser A., Gottwald A., Wiersch C., Maier W., Seitz H.M. The necessity to develop drugs against parasitic diseases. Pharmazie. 57:2002;723-728.
43. Lam K.S., Renil M. From combinatorial chemistry to chemical microarray. Curr. Opin. Chem. Biol. 6:2002;353-358.
44. Lima A.P., Almeida P.C., Tersariol I.L., Schmitz V., Schmaier A.H., Juliano L., Hirata I.Y., Muller-Esterl W., Chagas J.R., Scharfstein J. Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. J. Biol. Chem. 277:2002;5875-5881.
45. Lorger M., Engstler M., Homann M., Göringer H.U. Targeting the variable surface of African trypanosomes using VSG-specific, serum-stable RNA aptamers. Eukaryot. Cell. 2:2003;84-94.
46. Magdesian M.H., Giordano R., Ulrich H., Juliano M.A., Juliano L., Schumacher R.I., Colli W., Alves M.J. Infection by Trypanosoma cruzi. Identification of a parasite ligand and its host cell receptor. J. Biol. Chem. 276:2001;19382-19389.
47. Michiels F., Matthyssens G., Kronenberger P., Pays E., Dero B., Van Assel S., Darville M., Cravador A., Steinert M., Hamers R. Gene activation and re-expression of a Trypanosoma brucei variant surface glycoprotein. EMBO J. 2:1983;1185-1192.
48. Morgan G.W., Hall B.S., Denny P.W., Carrington M., Field M.C. The kinetoplastida endocytic apparatus. Part I: a dynamic system for nutrition and evasion of host defences. Trends Parasitol. 18:2002;491-496.
49. Morgan G.W., Hall B.S., Denny P.W., Field M.C., Carrington M. The endocytic apparatus of the kinetoplastida. Part II: machinery and components of the system. Trends Parasitol. 18:2002;540-546.
50. Morris K.N., Jensen K.B., Julin C.M., Weil M., Gold L. High affinity ligands from in vitro selection: complex targets. Proc. Natl. Acad. Sci. USA. 95:1998;2902-2907.
51. Ostendorf T., Kunter U., Grone H.J., Bahlmann F., Kawachi H., Shimizu F., Koch K.M., Janjic N., Floege J. Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J. Am. Soc. Nephrol. 12:2001;909-918.
52. Ouaissi M.A., Cornette J., Afchain D., Capron A., Gras-Masse H., Tartar A. Trypanosoma cruzi infection inhibited by peptides modeled from a fibronectin cell attachment domain. Science. 234:1986;603-607.
53. Overath P., Chaudri M., Steverding D., Ziegelbauer K. Invariant surface proteins in bloodstream forms of Trypanosoma brucei. Parasitol. Today. 10:1994;53-58.
54. Pays E., Nolan D.P. Expression and function of surface proteins in Trypanosoma brucei. Mol. Biochem. Parasitol. 91:1998;3-36.
55. Pecoul B., Chirac P., Trouiller P., Pinel J. Access to essential drugs in poor countries: a lost battle? J. Am. Med. Assoc. 281:1999;361-367.
56. Pieken W. Efficient process technologies for the preparation of oligonucleotides. Ciba Found. Symp. 209:1997;218-222.
57. Pieken W.A., Olsen D.B., Benseler F., Aurup H., Eckstein F. Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes. Science. 253:1991;314-317.
58. Reich M.R., Govindaraj R. Dilemmas in drug development for tropical diseases. Experiences with praziquantel. Health Policy. 44:1998;1-18.
59. Rice-Ficht A.C., Chen K.K., Donelson J.E. Point mutations during generation of expression-linked extra copy of trypanosome surface glycoprotein gene. Nature. 298:1982;676-679.
60. Ruckman J., Green L.S., Beeson J., Waugh S., Gillette W.L., Henninger D.D., Claesson-Welsh L., Janjic N. 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273:1998;20556-20567.
61. Rudenko G., Cross M., Borst P. Changing the end: antigenic variation orchestrated at the telomeres of African trypanosomes. Trends Microbiol. 6:1998;113-116.
62. Sullenger B.A., Gilboa E. Emerging clinical applications of RNA. Nature. 418:2002;252-258.
63. Takayanagi T., Enriquez G.L. Effects of the IgG and IgM Immunoglobulins in Trypanosoma gambiense infections in mice. J. Parasitol. 59:1973;644-647.
64. Tetley L., Vickerman K., Moloo S.K. Absence of a surface coat from metacyclic Trypanosoma vivax: possible implications for vaccination against vivax trypanosomiasis. Trans. R. Soc. Trop. Med. Hyg. 75:1981;409-414.
65. Tonge S.R., Tighe B.J. Responsive hydrophobically associating polymers: a review of structure and properties. Adv. Drug. Deliv. Rev. 53:2001;109-122.
66. Trouiller P., Torreele E., Olliaro P., White N., Foster S., Wirth D., Pecoul B. Drugs for neglected diseases: a failure of the market and a public health failure? Trop. Med. Int. Health. 6:2001;945-951.
67. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 249:1990;505-510.
68. Ulrich H., Alves M.J., Colli W. RNA and DNA aptamers as potential tools to prevent cell adhesion in disease. Braz. J. Med. Biol. Res. 34:2001;295-300.
69. Ulrich H., Magdesian M.H., Alves M.J.M., Colli W. In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J. Biol. Chem. 277:2002;20756-20762.
70. Urakawa T., Eshita Y., Majiwa P.A. The primary structure of Trypanosoma (Nannomonas) congolense variant surface glycoproteins. Exp. Parasitol. 85:1997;215-224.
71. White R.R., Sullenger B.A., Rusconi C.P. Developing aptamers into therapeutics. J. Clin. Invest. 106:2000;929-934.
72. Willis M.C., Hicke B.J., Uhlenbeck O.C., Cech T.R., Koch T.H. Photocrosslinking of 5-iodouracil-substituted RNA and DNA to proteins. Science. 262:1993;1255-1257.
73. Wilson D.S., Szostak J.W. In vitro selection of functional nucleic acids. Annu. Rev. Biochem. 68:1999;611-647.